TβRIII/β-arrestin2 regulates integrin α5β1 trafficking, function, and localization in epithelial cells

Oncogene

Volumn 32, Issue 11, 2013, Pages 1416-1427

  Mythreye, K ^a   Knelson, E H ^a   Gatza, C E ^a   Gatza, M L ^a   Blobe, G C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

b arrestin2; betaglycan; integrin a5b1; TGF b

Indexed keywords

ARRESTIN 2; FIBRONECTIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 5;

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CELL ADHESION; CELL MOTILITY; CELLULAR DISTRIBUTION; EPITHELIUM CELL; HUMAN; HUMAN CELL; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; ARRESTINS; CACO-2 CELLS; CELL ADHESION; CELLS, CULTURED; EPITHELIAL CELLS; FIBRONECTINS; HUMANS; INTEGRIN ALPHA5BETA1; K562 CELLS; MICE; MODELS, BIOLOGICAL; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN TRANSPORT; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TISSUE DISTRIBUTION;

EID: 84875222316     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.157     Document Type: Article

References (53)

1. Edelman GM, Crossin KL. Cell adhesion molecules: Implications for a molecular histology. Annu Rev Biochem 1991; 60: 155-190.
2. Ruoslahti E. Integrins. J Clin Invest 1991; 87: 1-5.
3. Loftus JC, Smith JW, Ginsberg MH. Integrin-mediated cell adhesion: The extracellular face. J Biol Chem 1994; 269: 25235-25238. (Pubitemid 24336196)
4. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991; 64: 867-869. (Pubitemid 121001173)
5. Burridge K, Chrzanowska-Wodnicka M. Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 1996; 12: 463-518.
6. Morgan MR, Byron A, Humphries MJ, Bass MD. Giving off mixed signals-distinct functions of alpha5beta1 and alphavbeta3 integrins in regulating cell behaviour. IUBMB Life 2009; 61: 731-738.
7. Bretscher MS. Cells can use their transferrin receptors for locomotion. Embo J 1992; 11: 383-389.
8. Pellinen T, Ivaska J. Integrin traffic. J Cell Sci 2006; 119(Part 18): 3723-3731. (Pubitemid 44614425)
9. Bretscher MS. Moving membrane up to the front of migrating cells. Cell 1996; 85: 465-467. (Pubitemid 26157185)
10. Lopez-Casillas F, Wrana JL, Massague J. Betaglycan presents ligand to the TGF beta signaling receptor. Cell 1993; 73: 1435-1444. (Pubitemid 23201155)
11. Kirkbride KC, Townsend TA, Bruinsma MW, Barnett JV, Blobe GC. Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor. J Biol Chem 2008; 283: 7628-7637.
12. Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM et al. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 2000; 404: 411-414. (Pubitemid 30164345)
13. Lopez-Casillas F, Payne HM, Andres JL, Massague J. Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites. J Cell Biol 1994; 124: 557-568. (Pubitemid 24064466)
14. Stenvers KL, Tursky ML, Harder KW, Kountouri N, Amatayakul-Chantler S, Grail D et al. Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos. Mol Cell Biol 2003; 23: 4371-4385. (Pubitemid 36666437)
15. Bilandzic M, Stenvers KL. Betaglycan: A multifunctional accessory. Mol Cell Endocrinol 2011; Apr: 28.
16. Blobe GC, Schiemann WP, Pepin MC, Beauchemin M, Moustakas A, Lodish HF et al. Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling. J Biol Chem 2001; 276: 24627-24637.
17. Blobe GC, Liu X, Fang SJ, How T, Lodish HF. A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC. J Biol Chem 2001; 276: 39608-39617.
18. Chen W, Kirkbride KC, How T, Nelson CD, Mo J, Frederick JP et al. Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling. Science 2003; 301: 1394-1397. (Pubitemid 37075818)
19. Lee NY, Kirkbride KC, Sheu RD, Blobe GC. The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors. Mol Biol Cell 2009; 20: 4362-4370.
20. Dong M, How T, Kirkbride KC, Gordon KJ, Lee JD, Hempel N et al. The type III TGFbeta receptor suppresses breast cancer progression. J Clin Invest 2007; 117: 206-217. (Pubitemid 46048467)
21. Finger EC, Turley RS, Dong M, How T, Fields TA, Blobe GC. TbetaRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity. Carcinogenesis 2008; 29: 528-535. (Pubitemid 351404868)
22. Gordon KJ, Dong M, Chislock EM, Fields TA, Blobe GC. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression. Carcinogenesis 2008; 29: 252-262. (Pubitemid 351359663)
23. Hempel N, How T, Dong M, Murphy SK, Fields TA, Blobe GC. Loss of betaglycan expression in ovarian cancer: Role in motility and invasion. Cancer Res 2007; 67: 5231-5238. (Pubitemid 46997261)
24. Turley RS, Finger EC, Hempel N, How T, Fields TA, Blobe GC. The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer. Cancer Research. (Research Support, N.I.H., Extramural Research Support, Non-US Gov't) 2007; 67: 1090-1098.
25. Bilandzic M, Chu S, Farnworth PG, Harrison C, Nicholls P, Wang Y et al. Loss of betaglycan contributes to the malignant properties of human granulosa tumor cells. Mol Endocrinol 2009; 23: 539-548.
26. Mythreye K, Blobe GC. The type III TGF-{beta} receptor regulates epithelial and cancer cell migration through {beta}-arrestin2-mediated activation of Cdc42. Proc Natl Acad Sci USA 2009; 106: 8221-8226.
27. White DP, Caswell PT, Norman JC. alpha v beta3 and alpha5beta1 integrin recycling pathways dictate downstream Rho kinase signaling to regulate persistent cell migration. J Cell Biol 2007; 177: 515-525. (Pubitemid 46718279)
28. Geiger B, Spatz JP, Bershadsky AD. Environmental sensing through focal adhesions. Nat Rev Mol Cell Biol 2009; 10: 21-33.
29. Parsons JT, Schaller MD, Hildebrand J, Leu TH, Richardson A, Otey C. Focal adhesion kinase: Structure and signalling. J Cell Sci Suppl 1994; 18: 109-113.
30. Hanks SK, Calalb MB, Harper MC, Patel SK. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci USA. 1992; 89: 8487-8491.
31. Schaller MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR, Parsons JT. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol 1994; 14: 1680-1688.
32. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA 1992; 89: 5192-5196.
33. Lee-Hoeflich ST, Causing CG, Podkowa M, Zhao X, Wrana JL, Attisano L. Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP-dependent dendritogenesis. Embo J 2004; 23: 4792-4801. (Pubitemid 40069709)
34. Liu F, Ventura F, Doody J, Massague J. Human type II receptor for bone morphogenic proteins (BMPs): Extension of the two-kinase receptor model to the BMPs. Mol Cell Biol 1995; 15: 3479-3486.
35. Akiyama SK, Yamada SS, Chen WT, Yamada KM. Analysis of fibronectin receptor function with monoclonal antibodies: Roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J Cell Biol 1989; 109: 863-875. (Pubitemid 19197044)
36. Kuwada SK, Li X. Integrin alpha5/beta1 mediates fibronectin-dependent epithelial cell proliferation through epidermal growth factor receptor activation. Mol Biol Cell 2000; 11: 2485-2496. (Pubitemid 30489929)
37. Clark K, Pankov R, Travis MA, Askari JA, Mould AP, Craig SE et al. A specific alpha5beta1-integrin conformation promotes directional integrin translocation and fibronectin matrix formation. J Cell Sci 2005; 118(Part 2): 291-300. (Pubitemid 40277342)
38. Ginsberg MH, Partridge A, Shattil SJ. Integrin regulation. Curr Opin Cell Biol 2005; 17: 509-516. (Pubitemid 41267165)
39. Woods AJ, White DP, Caswell PT, Norman JC. PKD1/PKCmu promotes alphavbeta3 integrin recycling and delivery to nascent focal adhesions. Embo J 2004; 23: 2531-2543. (Pubitemid 38988225)
40. Roberts MS, Woods AJ, Dale TC, Van Der Sluijs P, Norman JC. Protein kinase B/Akt acts via glycogen synthase kinase 3 to regulate recycling of alpha v beta 3 and alpha 5 beta 1 integrins. Mol Cell Biol 2004; 24: 1505-1515. (Pubitemid 38167074)
41. Zerial M, McBride H. Rab proteins as membrane organizers. Nature reviews Molecular Cell Biology. (Review) 2001; 2: 107-117. (Pubitemid 33674039)
42. Kohout TA, Lin FS, Perry SJ, Conner DA, Lefkowitz RJ. beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc Natl Acad Sci USA 2001; 98: 1601-1606. (Pubitemid 32165545)
43. Haenssen KK, Caldwell SA, Shahriari KS, Jackson SR, Whelan KA, Klein-Szanto AJ et al. ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells. Journal of Cell Science. (Research Support, US Gov't, Non-P.H.S.) 2010; 123(Part 8): 1373-1382.
44. Molteni R, Crespo CL, Feigelson S, Moser C, Fabbri M, Grabovsky V et al. Betaarrestin 2 is required for the induction and strengthening of integrin-mediated leukocyte adhesion during CXCR2-driven extravasation. Blood. (Research Support, Non-U.S. Gov't) 2009; 114: 1073-1082.
45. DeFea KA. Stop that cell! Beta-arrestin-dependent chemotaxis: A tale of localized actin assembly and receptor desensitization. Annu Rev Physiol 2007; 69: 535-560. (Pubitemid 46457654)
46. Toutant M, Costa A, Studler JM, Kadare G, Carnaud M, Girault JA. Alternative splicing controls the mechanisms of FAK autophosphorylation. Mol Cell Biol 2002; 22: 7731-7743. (Pubitemid 35217285)
47. Wu X, Suetsugu S, Cooper LA, Takenawa T, Guan JL. Focal adhesion kinase regulation of N-WASP subcellular localization and function. J Biol Chem 2004; 279: 9565-9576. (Pubitemid 38296025)
48. Mythreye K, Blobe GC. Proteoglycan signaling co-receptors: Roles in cell adhesion, migration and invasion. Cell Signal 2009; May: 8.
49. Nam JM, Onodera Y, Bissell MJ, Park CC. Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin. Cancer Research. (Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, US Gov't, Non-P.H.S.) 2010; 70: 5238-5248.
50. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10 A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003; 30: 256-268. (Pubitemid 36677560)
51. You HJ, Bruinsma MW, How T, Ostrander JH, Blobe GC. The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation. Carcinogenesis. (Research Support, N.I.H., Extramural Research Support, Non-US Gov't) 2007; 28: 2491-2500. (Pubitemid 350238951)
52. Robertson D, Savage K, Reis-Filho JS, Isacke CM. Multiple immunofluorescence labelling of formalin-fixed paraffin-embedded (FFPE) tissue. BMC Cell Biol. (Research Support, Non-US Gov't) 2008; 9: 13.
53. Roberts M, Barry S, Woods A, van der Sluijs P, Norman J. PDGF-regulated rab4-dependent recycling of alphavbeta3 integrin from early endosomes is necessary for cell adhesion and spreading. Curr Biol 2001; 11: 1392-1402. (Pubitemid 32863188)